loading

Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 11.13 2.2616
Operating Expenses
5.18%
26.28
27.72 24.98 18.83 15.27
Operating Income/Loss
5.18%
-26.28
-27.72 -24.98 -7.6978 -13.01
Nonoperating Income/Loss
5.25%
1.7134
1.8083 0.5914 0.5812 0.4532
Income/Loss From Continuing Operations Before Tax
5.17%
-24.57
-25.91 -24.39 -7.1166 2.2616
Income/Loss From Continuing Operations After Tax
5.17%
-24.57
-25.91 -24.39 -7.1166 -12.56
Net Income/Loss
5.17%
-24.57
-25.91 -24.39 -7.1166 -12.56
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.02%
45.72
45.71 45.64 3.1194 33.09
Diluted Average Shares
0.02%
45.72
45.71 45.64 3.1194 33.09
Basic Earnings Per Share
5.26%
-0.54
-0.57 -0.53 -0.11 -0.38
Diluted Earnings Per Share
5.26%
-0.54
-0.57 -0.53 -0.11 -0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):